tbuckley/cabot-search huggingface dataset:
Errata
Authors: D Mnoon, L Steele, Tlhomas Parry, F Jaclkssn, H Tomrlinson, Genieral Infirmary, Leeds Walsh, P Wellington, R Ilcnislowe, Sutton Willett, Geoi-Ge Drake, Reappointed Myedical
Journal: BMJ (1891)

WOODFORDE,M
Normal-pressure hydrocephalus and psychiatric disorders.
Journal: BMJ (1973)

not be given in pregnancy nor to infants because of their action on teeth and bones.If erythromycin is given, the base, not the estolate, should be used because of the risk of liver damage with the latter.L. Z. Oller7 has reported treating an early infection in a pregnant woman who was sensitive to penicillin with 2 g cephaloridine daily in divided doses for 14 days.In a series of patients with early syphilis reported by A. L. Schroeter and his colleagues8 retreatment rates after tetracycline and erythromycin were higher than after peni- cillin.When resort to these alternatives is necessary, careful follow-up is essential.
THE BUSY PRACTITIONER AND HIS OPPORTUNITIES.
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Do Moral Principles Change?
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height
Authors: F. Comite
Journal: JAMA (1986)

The long-acting analogue of luteinizing hormone releasing hormone, D-Trp<sup>6</sup>-Pro<sup>9</sup>-NEt-LHRH (LHRH<sub>a</sub>), is effective in the short-term treatment of central precocious puberty. We report the results of two to four years of LHRH<sub>a</sub>therapy in 27 children with this disorder. Secondary sex characteristics regressed in most patients. Sex steroid levels and basal and LHRH-stimulated gonadotropin levels remained suppressed compared with pretreatment values. Linear growth rates decreased from 11.0±0.8 (SEM) cm/yr before treatment to 5.7 ±0.4 cm/yr at two years of treatment and 3.7±0.7 cm/yr at four years of treatment. Predicted heights by the Bayley-Pinneau method increased from 156.4 ±2.0 cm before treatment to 162.3 ±2.3 cm at two years and 163.4 ±2.4 cm at three years. Five patients treated for four years had a mean increase in predicted height of 5.5 cm. To date no adverse effects have been observed. However, the ultimate safety of this analogue is not known. We conclude that LHRH<sub>a</sub>appears to be an effective long-term therapy for central precocious puberty. (<i>JAMA</i>1986;255:2613-2616)
Drug-induced illness leading to hospitalization
Authors: G. J. Caranasos
Journal: JAMA (1974)

During a three-year period, drug-induced illness, excluding suicide attempts and drug abuse, accounted for 2.9% of admissions to a medical service. There were proportionately fewer admissions for patients under 61 years of age than for those over. A considerably greater number of white women than black women or men were affected. More than 6% of these patients died. Eight drugs (aspirin, digoxin, warfarin sodium, hydrochlorothiazide, prednisone, vincristine sulfate, norethindrone, and furosemide) produced a third of the illnesses. In 18% of the cases an over-the-counter drug was implicated. Hemorrhagic effects occurred frequently. The cardiovascular, gastrointestinal, and hemopoietic systems were most often involved. Drug allergy was the mechanism of the adverse drug effect in 17.6% of the illnesses. The remainder were due to pharmacological mechanisms. (JAMA 228:713-717, 1974)
Barrett's Esophagus
Authors: Stuart Jon Spechler, Raj K. Goyal
Journal: New England Journal of Medicine (1986)

BARRETT'S esophagus is a condition in which the squamous mucosa that normally lines the distal esophagus is replaced by a columnar epithelium resembling that in the stomach and intestines. This aberrant epithelium may be the site of esophageal ulceration, stricture, and adenocarcinoma. Early misconceptions and ongoing controversies regarding the definition, pathogenesis, and clinical features of Barrett's esophagus have resulted in persistent confusion about the disorder. Recent studies have clarified some of these issues substantially. The purpose of this report is to review critically some of the controversies about Barrett's esophagus and to describe the recent advances in our understanding of . . .
J Neuropathology &amp;amp; Exp Neurology, Baltimore
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A N OPERATION FOR VALGUS FEET
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Two Hearts
Authors: Joan I. Siegel
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Maize Adh1 as a Monitor of Environmental Mutagens
Authors: Michael Freeling
Journal: Environmental Health Perspectives (1978)

The maize Adh1 gene is introduced, with citations. The use of this gene as a mutagen monitor is discussed, with emphasis on differentiating quantitative and qualitative parameters. A proper assessment of hazard from environmental pollutants requires data on possible mutagen specificities for different kinds of DNA.
Error in Table
Authors: N Rosman, Jodi Abbott, Rachel Vassar
Journal: JAMA Pediatrics (2018)

Maala Bhatt, MD, MSc; David W. Johnson, MD; Monica Taljaard, PhD; Jason Chan, MSc; Nick Barrowman, PhD; Ken J. Farion, MD; Samina Ali, MD; Suzanne Beno, MD; Andrew Dixon, MD; C. Michelle McTimoney, MD; Alexander Sasha Dubrovsky, MD; Mark G. Roback, MD; for the Sedation Safety Study Group of Pediatric Emergency Research Canada
Guideline adherence rates of chemotherapy treatment for colon cancer patients treated in U.S. community oncology practices.
Authors: Z. Wang, K. A. Bergstrom, I. Aksamit, L. Tuscher, T. Lam, B. S. Tom, C. G. Baker, K. B. Whitlock, Z. Ansari-Jaberi, M. Mayo
Journal: Journal of Clinical Oncology (2010)

3620 Background: Adherence to national guidelines is a key step to improving the quality and outcomes of cancer treatment in the United States. This study examined guideline adherence rates and cost of chemotherapy treatment for colon cancer patients treated in the adjuvant (Adj) and first-line metastatic (Met) settings in U.S. community oncology practices. Methods: Using a large, U.S. medical oncology clinical database derived from a web-based drug dispensing technology, adult patients with colon cancer treated with Adj and Met chemotherapy were identified from 1/1/09-12/31/09. Regimens utilized were compared to national guidelines. Costs based on Medicare reimbursement were also compared. Results: A total of 1,380 Adj and 1,596 first-line Met regimens were administered by 383 practices across 45 states. Median patient age was 64 and 65 in the Adj and Met groups, respectively. The Adj and Met groups received 54 and 108 different regimens, respectively. The rate of guideline adherence in the Adj group, 80.9%, was significantly higher than in the Met group, 76.5% (p<0.001 by Chi test). The top 5 regimens utilized in the Adj group were given to 80% of all patients, while in the Met group 60% were given. All 10 regimens were appropriate according to guidelines, except CAPOX in the Adj setting. Regimen costs based on Medicare national reimbursement rates (including antineoplastic and supportive care drugs, CPT, and some lab codes) for the top 5 regimens in the Adj and Met settings varied considerably. A standard course of therapy in the Adj setting (6 months) ranged from $12,459 for 5FU-LV to $51,242 for CAPOX. Regimen costs in the Met setting ranged from $5,300 for FOLFIRI to $39,682 for CAPOX + Bev based on 3 months of therapy. Conclusions: The guideline adherence rate for regimens utilized in the community oncology setting is significantly higher in the Adj setting than the Met setting. Costs for the top 5 regimens in the Adj and Met settings vary considerably. Adj regimen % 5- fluororucil (5FU) + leucovorin (LV) + oxaliplatin (Ox) (mFOLFOX6) 56 5FU + LV + OX (FOLFOX4) 14 Capecitabine + OX (CAPOX) 5 5FU + LV 3 5FU + LV + OX (FLOX) 2 Met regimen % mFOLFOX6 + bevacizumab (Bev) 32 5FU + LV + irinotecan + Bev (FOLFIRI + Bev) 13 CAPOX + Bev 5 FOLFIRI 5 mFOLFOX6 5 Author Disclosure Employment or Leadership Position Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration McKesson Amgen, McKesson
From the Centers for Disease Control. Progress toward achieving the 1990 objectives for the Nation for fluoridation and dental health
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
RIO DE JANEIRO
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Caloric Balance and Intravenous Lipids
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mucosal inflammation in severe glucocorticoid-dependent asthma
Authors: B. Vrugt, S Wilson, J Underwood, A. Bron, R. de Bruyn, P Bradding, S.T. Holgate, R Djukanovic, R. Aalbers
Journal: European Respiratory Journal (1999)

To improve our understanding of the inflammatory mechanisms underlying severe disease, a biopsy study was performed comparing 15 clinically unstable glucocorticoid-dependent asthmatics, 10 mild asthmatics, and 10 control subjects. Compared with mild asthma, severe asthma was characterized by reduced mucosal eosinophilia. Whilst no significant differences were found in the numbers of mast cells, neutrophils, CD3+ and CD4+ T-cells between the three groups, up to a 4-fold increase In the numbers of activated T-lymphocytes bearing the interleukin (IL)-2 receptor (IL-2R) was found in the mucosa in severe asthma compared to mild asthma (p = 0.03) and control subjects (p = 0.003). Compared to control subjects, the mucosa of severe asthmatics contained significantly (p = 0.02) higher numbers of IL-5+ cells, with no differences between mild and severe disease. In contrast, staining for the anti-IL-4 monoclonal antibody 3H4 revealed that biopsies from mild asthmatics contained more IL4+ cells than biopsies from severe asthmatics and control subjects (p = 0.0008). In the severe asthmatics, a close correlation (r(s) = 0.76, p = 0.005) was found between the numbers of IL-2R-bearing cells and the variability in peak expiratory flow. In conclusion, persistent T-cell activation is a prominent feature of severe asthma. These results also indicate that interleukin-5, and not interleukin-4, is upregulated in severe disease.
Flexible fiberoptic colonoscopy. A guide for its use in the management of diseases of the colon
Authors: G. Marks
Journal: JAMA (1974)

The flexible fiberoptic instrument, developed for inspection of the lumen of the colon, has had sufficient clinical trial to warrant a description of its feasibility, capabilities, reliability, hazards, indications, contraindications, and expense-yield ratio in the diagnosis and management of colonic disorders. This method of examination of the colonic mucosa permits visualization of many abnormalities that escape radiographic and sigmoidoscopic detection. Should the first-line diagnostic efforts of barium enema examination and sigmoidoscopy be less than consistent with other clinical features, colonoscopy is indicated. Diagnosis and removal of polyps add to the enormous impact of flexible fiberoptic colonscopy on the management of colonic disorders. (<i>JAMA</i>228:1411-1413, 1974)
The Bends
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Giant cell arteritis.
Authors: J. C. Mason, M. J. Walport
Journal: BMJ (1992)

also to the public and the media.One suggestion is to produce a version of Health Technology Trends, an American journal that resembles a Which?review of competing technologies, which could act as a clearing house for data on health technology assessment.Another national initiative should be to ensure that health technology assessment is given due prominence in the training of doctors and managers.Eventually, however, managers may have to introduce incentives to encourage doctors to take health technology assessment into account when making decisions about priorities and practice.Perhaps new technology should be provided only if the users promise to evaluate it.This requires the recognition that time spent on evaluation is important.Some fear that the emphasis on work related clinical contracts and maximising cost efficient delivery may reduce the time that doctors are willing to spend on research, which may come to be associated with other paymasters such as the Medical Research Council or the universities.It is therefore reassuring to have such a clear acknowledgement by the NHS of the importance of health technology assessment and the recognition of its need for substantial funding.Also that the NHS and MRC have once again declared the importance of joint efforts in health service research and clinical trials.12